IMPROVING THE COMPETITIVENESS OF IMEXPHARM PHARMACEUTICAL JOINT STOCK COMPANY IN THE INTERGRATING PROCESS

Abstract

The outbreak of the Covid-19 pandemic underscores shows how important it is to take care of  your health. Owning two factories meeting EU-GMP standards, capable of producing high-quality drugs for the hospital channel, replacing many high-priced imported drugs, Imexpharm pharmaceutical joint stock company is a famous face in the world. market. Therefore, finding a solution to improve competitiveness, at Imexpharm company in a sustainable way, able to adapt to the global competitive environment is essential.